Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Cost of Goods Sold

Aquestive Therapeutics Inc Cost of Goods Sold Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Cost of Goods Sold from 2017 to 2020.
  • Aquestive Therapeutics Inc Cost of Goods Sold for the quarter ending March 03, 2020 was $4m a -48.13% decrease of -2m year over year
  • Aquestive Therapeutics Inc Cost of Goods Sold for the last 12 months ending March 03, 2020 was $21m a 5.89% increase of 1m year over year
  • Aquestive Therapeutics Inc Annual Cost of Goods Sold for 2019 was $20m a -3.08% decrease of -1m from 2018
  • Aquestive Therapeutics Inc Annual Cost of Goods Sold for 2018 was $21m a 5.57% increase of 1m from 2017
  • Aquestive Therapeutics Inc Annual Cost of Goods Sold for 2017 was $20m a 17.37% increase of 3m from 2016
Other Income Statement Metrics:
  • Aquestive Therapeutics Inc EBITDA for the quarter ending December 12, 2018 was $-12m a 154.38% decrease of -18m year over year
  • Aquestive Therapeutics Inc Net Income for the quarter ending December 12, 2018 was $-14m a 129.40% decrease of -18m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Cost of Goods Sold Data

03/2020$4m
12/2019$7m
09/2019$5m
06/2019$5m
03/2019$4m
12/2018$5m
09/2018$6m
06/2018$5m
03/2018$6m
12/2017$6m

Annual AQST Cost of Goods Sold Data

2019$20m
2018$21m
2017$20m
2016$16m